DRACONIS PHARMA
Research of immunological response
The expertise you value. The experience you need. The flexibility you want
Discovery and Preclinical Services
Draconis Pharma provides drug discovery and non-regulatory preclinical development services with an expertise and depth-knowledge in the field of inflammation/Immunology, DMPK, Toxicology and Bioanalysis.
R&D
Draconis Pharma expertise is focused on the drug discovery and preclinical development of novel immune-related therapies in the field of inflammation, autoimmune and immuno-oncology diseases.
The expertise you value. The experience you need. The flexibility you want
Draconis Pharma focuses on researching immunological responses and developing new therapies to treat immune-based diseases, including inflammation, autoimmunity, allergy, and related conditions such as cancer and pain.
Draconis provides experimental services for early-stage discovery and pre-clinical research to pharmaceutical, biotech, and food companies. With its scientific expertise, Draconis offers highly customized experimental models to evaluate the efficacy, drugability, safety, and toxicology of new research therapies. Our scientific team has developed assays for different types of therapeutic agents including small molecules, therapeutic proteins, antibodies, RNA-based compounds, vaccines, functional foods, plant extracts and probiotics.
Our Benefits
Expertise & Knowledge
Our team is focused on the discovery and preclinical development, with an in-depth understanding of immunology, inflammatory processes, and ADME-DMPK studies
Tailor-made experimental designs
Consult with our expert Immunology and ADME/DMPK specialists to discuss your project requirements
Project monitoring
We maintain ongoing communication with the client throughout the study/s execution
Reliable results
Interpretation of the results is based on our extensive experience and knowledge in drug discovery and preclinical development